Warner Pharmaceutical (688799.SH): Iron Succinate Tablets and others are expected to be selected for national centralized drug procurement.

According to the Smart Finance APP, Warner Pharmaceuticals (688799.SH) announced that on July 31, 2026, the company participated in the bidding for the 12th batch of national centralized procurement organized by the National Organization for Drug Procurement Office. The company's ferrous succinate tablets and diclofenac sodium sustained-release tablets are expected to be selected for this centralized procurement.